Search
for
Sort by
Research 31–60 of 346
- Dermatological drugs, topical agents, and cosmetics
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Skin manifestations associated with COVID-19
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Dermatological lesions among people living with HIV in Turkey
- Severe and Fatal Phenobarbitone Eruptions
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- An Update on Drug-Induced Pigmentation
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- Generalized maculopapular rash and fever
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Anticonvulsant-Induced Cutaneous Reactions
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Skin disorders associated with the COVID‐19 pandemic: A review
- The Skin and Subcutaneous Tissues
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Cutaneous manifestations of COVID-19
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog